Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Black, S.
Li, H.
McRae, T.
Richardson, S.
机构：
[1] Sunnybrook & Womens Coll, Toronto, ON, Canada
[2] Pfizer Inc, New York, NY USA
[3] Eisai Inc, Teaneck, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [21] Efficacy of donepezil on secondary end points in a randomized, double-blind, placebo-controlled study in severe Alzheimer's disease
    Winblad, B
    Eriksson, S
    Kilander, L
    Båtsman, S
    Jansson-Blix, C
    Wetterholm, AL
    Haglund, A
    Minthon, L
    [J]. NEUROLOGY, 2006, 66 (05) : A350 - A350
  • [22] Efficacy of donepezil on primary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease
    Winblad, B
    Minthon, L
    Eriksson, S
    Batsman, S
    Jansson-Blixt, C
    Wetterholm, AL
    Haglund, A
    Kilander, L
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 238 - 239
  • [23] Donepezil-treated patients with vascular dementia demonstrate cognitive and global benefits: Results from study 308, a 24-week, randomized, double-blind, placebo-controlled trial
    Salloway, S
    Pratt, RD
    Perdomo, CA
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S57 - S57
  • [24] Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease - A 24-week, multicenter, double-blind, placebo-controlled study in Japan
    Homma, A
    Takeda, M
    Imai, Y
    Udaka, F
    Hasegawa, K
    Kameyama, M
    Nishimura, T
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (06) : 299 - 313
  • [25] DONEPEZIL SIGNIFICANTLY IMPROVES ABILITIES IN DAILY LIVES OF FEMALE DOWN SYNDROME PATIENTS WITH SEVERE COGNITIVE IMPAIRMENT: A 24-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kondoh, Tatsuro
    Kanno, Atsushi
    Itoh, Hiroshi
    Nakashima, Mikiro
    Honda, Ryoko
    Kojima, Michio
    Noguchi, Mitsuru
    Nakane, Hideyuki
    Nozaki, Hidetsugu
    Sasaki, Hitoshi
    Nagai, Toshiro
    Kosaki, Rika
    Kakee, Naoko
    Okuyama, Torayuki
    Fukuda, Masafumi
    Ikeda, Masayuki
    Shibata, Yoshisada
    Moriuchi, Hiroyuki
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2011, 41 (01): : 71 - 89
  • [26] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    [J]. NEUROLOGY, 2015, 85 (16) : 1383 - 1391
  • [27] Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial
    Zemlan, FP
    Folks, DG
    Goldstein, BJ
    Gottlieb, G
    Holub, RF
    Linden, RD
    Margolin, RA
    Richter, RW
    Speakman, WF
    Strub, RL
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) : 1105 - 1116
  • [28] Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trial
    Halvorsen, Yuan-Di
    Conery, Annie L.
    Lock, John Paul
    Zhou, Wenjiong
    Freeman, Mason W.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2954 - 2962
  • [29] Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease:: A 26-week randomized, placebo-controlled, double-blind trial
    Simons, M
    Schwärzler, F
    Lütjohann, D
    von Bergmann, K
    Beyreuther, K
    Dichgans, J
    Wormstall, H
    Hartmann, T
    Schulz, JB
    [J]. ANNALS OF NEUROLOGY, 2002, 52 (03) : 346 - 350
  • [30] A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease
    Alvarez, XA
    Cacabelos, R
    Laredo, M
    Couceiro, V
    Sampedro, C
    Varela, M
    Corzo, L
    Fernandez-Novoa, L
    Vargas, M
    Aleixandre, M
    Linares, C
    Granizo, E
    Muresanu, D
    Moessler, H
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (01) : 43 - 54
12345